Myasthenic crisis (MC) requiring mechanical ventilation (MV) is a rare and serious complication of myasthenia gravis. Here we analyzed the frequency of performed tracheostomies, risk factors correlating with a tracheostomy, as well as the impact of an early tracheostomy on ventilation time and ICU length of stay (LOS) in MC.
Methods:
Retrospective chart review on patients treated for MC in 12 German neurological departments between 2006 and 2015 to assess demographic/diagnostic data, rates and timing of tracheostomy and outcome.
Results:
In 107 out of 215 MC (49.8%), a tracheostomy was performed. Patients without tracheostomy were more likely to have an early-onset myasthenia gravis (27 [25.2%] vs 12 [11.5%], p = 0.01). Patients receiving a tracheostomy, however, were more frequently suffering from multiple comorbidities (20 [18.7%] vs 9 [8.3%], p = 0.03) and also the ventilation time (34.4 days ± 27.7 versus 7.9 ± 7.8, p < 0.0001) and ICU-LOS (34.8 days ± 25.5 versus 12.1 ± 8.0, p < 0.0001) was significantly longer than in non-tracheostomized patients. Demographics and characteristics of the course of the disease up to the crisis were not significantly different between patients with an early (within 10 days) compared to a late tracheostomy. However, an early tracheostomy correlated with a shorter duration of MV at ICU (26.2 days ± 18.1 versus 42.0 ± 33.1, p = 0.006), and ICU-LOS (26.2 days ± 14.6 versus 42.3 ± 33.0, p = 0.003).
Conclusion:
Half of the ventilated patients with MC required a tracheostomy. Poorer health condition before the crisis and late-onset MG were associated with a tracheostomy. An early tracheostomy (≤ day 10), however, was associated with a shorter duration of MV and ICU-LOS by 2 weeks.
MelzerNRuckTFuhrP, et al.Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German neurological society. J Neurol. 2016;263(8):1473–1494. Accessed March 16, 2016.
PhillipsLH2nd. The epidemiology of myasthenia gravis. Ann NY Acad Sci. 2003;998(1):407–412.
5.
FinkME. Treatment of the critically ill patient with myasthenia gravis. In: RopperAH (ed) Neurological and Neurosurgical Intensive Care, 3rd edn. Raven Press, 1993:351–362.
6.
ThomasCEMayerSAGungorY, et al.Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48(5):1253–1260.
7.
AlshekhleeAMilesJDKatirjiBPrestonDCKaminskiHJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72(18):1548–1554.
Ramos-FransiARojas-GarcíaRSegoviaS, et al.Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry. Eur J Neurol. 2015;22(7):1056–1061.
11.
RonagerJRavnborgMHermansenIVorstrupS. Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artifi Organs. 2001;25(12):967–973.
12.
GajdosPChevertSClairBTranchantCChastangC.Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. myasthenia gravis clinical study. Ann Neurol. 1997;41(6):789–796.
13.
GoldRKrenzerMKlinkerE, et al.Efficacy and safety of immunoadsorption vs plasmapheresis vs combination for treatment of myasthenic crisis: comparative retrospective study on 72 patients. Neurology. 2008;70(11):A427–A427.
14.
AndersonCDBartscherJFScripkoPD, et al.Neurologic examination and extubation outcome in the neurocritical care unit. Neurocritical Care. 2011;15(3):490–497.
15.
SeneviratneJMandrekarJWijdicksEFMRabinsteinAA. Predictors of extubation failure in myasthenic crisis. Arch Neurol. 2008;65(7):929–933.
16.
WuJ-YKuoP-HFanP-CWuH-DShihF-YYangP-C. The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis. Neurocrit Care. 2009;10(1):35–42. Accessed March 18, 2016.
17.
LiuZYaoSZhouQ, et al.Predictors of extubation outcomes following myasthenic crisis. J Int Med Res. 2016;44(6):1524–1533.
18.
RabinsteinAAMueller-KronastN. Risk of extubation failure in patients with myasthenic crisis. Neurocrit Care. 2005;3(3):213–215.
19.
MacIntyreNR. Evidence-based guidelines for weaning and discontinuing ventilatory support. Chest. 2001;120(6):375–395. Accessed October 12, 2016.
20.
van der LelyAJVeeloDPDongelmansDA, et al.Time to wean after tracheotomy differs among subgroups of critically ill patients: retrospective analysis in a mixed medical/surgical intensive care unit. Respir Care. 2006;51(12):1408–1415.
21.
GriffithsJBarberVSMorganLYoungJD. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ (Clinical Research Ed.). 2005;330(7502):1243.
22.
BoselJSchillerPHookY, et al.Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial (setpoint): a randomized pilot trial. Stroke. 2012;44(1):21–28.
23.
RumbakMJNewtonMTruncaleTSchwartzSWAdamsJWHazardPB. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med. 2004;32(8):1689–1694.
24.
AndrioloBNGAndrioloRBSaconatoHAtallahÁNValenteO. Early versus late tracheostomy for critically ill patients. Cochrane Database Syst Rev. 2015;60(1):91.
Gomes SilvaBNAndrioloRBSaconatoHAtallahANValenteO. Early versus late tracheostomy for critically ill patients. Cochrane Database Syst Rev. 2012;(3):CD007271.
27.
BlotFSimilowskiTTrouilletJ-L, et al.Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients. Intensive Care Med. 2008;34(10):1779–1787.
28.
TrouilletJ-LLuytC-EGuiguetM, et al.Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial. Ann Inter Med. 2011;154(6):373–383.
29.
TerragniPPAntonelliMFumagalliR, et al.Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA. 2010;303(15):1483–1489.
AlsherbiniKGoyalNMetterEJ, et al.Predictors for tracheostomy with external validation of the stroke-related early tracheostomy score (SETscore). Neurocritical Care. 2019;30(1):185–192.
32.
GoettlerCEFugoJRBardMR, et al.Predicting the need for early tracheostomy: a multifactorial analysis of 992 intubated trauma patients. J Trauma. 2006;60(5):991–996.
33.
SanabriaAGómezXVegaVDomínguezLCOsorioC. Prediction of prolonged mechanical ventilation in patients in the intensive care unit: a cohort study. Colombia Med (Cali, Colombia). 2013;44(3):184–188.
34.
SteidlCBöselJSuntrup-KruegerS, et al.Tracheostomy, extubation, reintubation: airway management decisions in intubated stroke patients. Cerebrovasc Dis (Basel, Switzerland). 2017;44(1-2):1–9.
35.
ArabiYMAlhashemiJATamimHM, et al.The impact of time to tracheostomy on mechanical ventilation duration, length of stay, and mortality in intensive care unit patients. J Crit Care. 2009;24(3):435–440. doi:10.1016/j.jcrc.2008.07.001. Epub January 17, 2009. Accessed September 28, 2016. https://www.ncbi.nlm.nih.gov/pubmed/19327302
36.
Van der LelyAJVeeloDPDongelmansDAKorevaarJCVroomMBSchultzMJ. Time to wean after tracheotomy differs among subgroups of critically ill patients: retrospective analysis in a mixed medical/surgical intensive care unit. Respir Care. 2006;51(12):1408–1415.
37.
QureshiAISuarezJIParekhPDBhardwajA. Prediction and timing of tracheostomy in patients with infratentorial lesions requiring mechanical ventilatory support. Crit Care Med. 2000;28(5):1383–1387.
WerneckLCScolaRHGerminianiFMComerlatoEACunhaFM. Myasthenic crisis: report of 24 cases. Arquivos de Neuro-Psiquiatria. 2002;60(3A):519–526. Accessed March 14, 2016. http://www.scielo.br/pdf/anp/v60n3A/11118.pdf
40.
O’RiordanJIMillerDHMottersheadJPHirschNPHowardRS. The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit. Eur J Neurol. 1998;5(2):137–142.
41.
RabinsteinAAWijdicksEFM. Weaning from the ventilator using BiPAP in myasthenia gravis. Muscle & Nerve. 2003;27(2):252–253.
42.
BouderkaMAFakhirBBouaggadAHmamouchiBHamoudiDHartiA. Early tracheostomy versus prolonged endotracheal intubation in severe head injury. J Trauma. 2004;57(2):251–254.
43.
AlaliASScalesDCFowlerRA, et al.Tracheostomy timing in traumatic brain injury: a propensity-matched cohort study. J Trauma Acute Care Surg. 2014;76(1):70–76; discussion 76-8.
44.
TeohWHGohKYChanC. The role of early tracheostomy in critically ill neurosurgical patients. Ann Acad Med Singap. 2001;30(3):234–238.
45.
Do Valle PinheiroBde Oliveira TostesRBrumCI, et al.Early versus late tracheostomy in patients with acute severe brain injury. J Bras Pneumol. 2010;36(1):84–91.
46.
DunhamCMCutronaAFGruberBSCalderonJERansomKJFlowersLL. Early tracheostomy in severe traumatic brain injury: evidence for decreased mechanical ventilation and increased hospital mortality. Int J Burn Trauma. 2014;4(1):14–24.
47.
AhmedNKuoY-H. Early versus late tracheostomy in patients with severe traumatic head injury. Surg Infect. 2007;8(3):343–347.
48.
WangSHXieYCJiangB, et al.Fluoroquinolone associated myasthenia gravis exacerbation: clinical analysis of 9 cases. Zhonghua Yi Xue Za Zhi. 2013;93(17):1283–1286.
49.
PerrotXBernardNVialC, et al.Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment. Neurology. 2006;67(12):2256–2258.
50.
JonesSCSorbelloABoucherRM. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf. 2011;34(10):839–847.
51.
RossiMLusiniGBiasellaAMazzocchioR. Prulifloxacin as a trigger of myasthenia gravis. J Neurol Sci. 2009;280(1-2):109–110.
